Cargando…

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study

BACKGROUND: The Swiss Federal Office of Public Health has recommended vaccination against human papillomavirus (HPV) to prevent cervical cancer since 2008. To establish monitoring of the future public health impact of vaccination, baseline population-based data are required. The objectives of this s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egli-Gany, Dianne, Spaar Zographos, Anne, Diebold, Joachim, Masserey Spicher, Virginie, Frey Tirri, Brigitte, Heusser, Rolf, Dillner, Joakim, Petignat, Patrick, Sahli, Roland, Low, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354352/ https://www.ncbi.nlm.nih.gov/pubmed/30700274 http://dx.doi.org/10.1186/s12885-018-5248-y

Ejemplares similares

Human papillomavirus vaccine uptake in adolescence and adherence to cervical cancer screening in Switzerland: a national cross-sectional survey
por: Wymann, Monica N., et al.
Publicado: (2017)

Patterns of Human Papillomavirus Types in Multiple Infections: An Analysis in Women and Men of the High Throughput Human Papillomavirus Monitoring Study
por: Vaccarella, Salvatore, et al.
Publicado: (2013)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Expressed Prostate Secretions in the Study of Human Papillomavirus Epidemiology in the Male
por: Smelov, Vitaly, et al.
Publicado: (2013)

Overexpression of programmed cell death ligand 1 in patients with CIN and its correlation with human papillomavirus infection and CIN persistence
por: Sancakli Usta, Ceyda, et al.
Publicado: (2020)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines
por: Demarco, Maria, et al.
Publicado: (2017)

The Launch of an International Animal Papillomavirus Reference Center
por: Van Doorslaer, Koenraad, et al.
Publicado: (2019)

An opportunity to increase human papillomavirus vaccination rates: Change the guidelines
por: Aragones, Abraham, et al.
Publicado: (2022)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Human papillomavirus self‐sampling with mRNA testing benefits routine screening
por: Auvinen, Eeva, et al.
Publicado: (2022)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
por: Baussano, Iacopo, et al.
Publicado: (2014)

Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer
por: Spinillo, Arsenio, et al.
Publicado: (2020)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

microRNAs’ differential regulations mediate the progress of Human Papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN)
por: Mo, Wenjuan, et al.
Publicado: (2015)

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
por: Leval, Amy, et al.
Publicado: (2013)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates
por: Baussano, Iacopo, et al.
Publicado: (2013)

Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
por: Andersson, S, et al.
Publicado: (2005)

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2010)

Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review
por: Skoulakis, Anargyros, et al.
Publicado: (2019)

Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study
por: Casajuana-Pérez, Andrea, et al.
Publicado: (2022)

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey
por: Riesen, Maurane, et al.
Publicado: (2018)

Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high‐risk human papillomavirus‐positive population
por: Ebisch, Renée M. F., et al.
Publicado: (2022)

The Role of Methylation of Host and/or Human Papillomavirus (HPV) DNA in Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Lesions
por: Dovnik, Andraž, et al.
Publicado: (2023)

Epidemiological, behavioural, and clinical factors associated with antimicrobial-resistant gonorrhoea: a review
por: Abraha, Million, et al.
Publicado: (2018)

Clearance and persistence of the human papillomavirus infection among Cameroonian women
por: Akaaboune, Mohamed, et al.
Publicado: (2018)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China
por: Zhang, Qiaoyu, et al.
Publicado: (2020)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

Human Polyomaviruses and Papillomaviruses
por: Moens, Ugo
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fbp61lorol9ei37bd0nc8cbrfo